|
|
|
AREDS2 DNA Detail
|
|
|
| Records Return:
(53)
|
|
|
|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0165 | ED148635 | General Research Use | No | Male | White | 71 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0290 | ED148747 | General Research Use | No | Male | White | 78 | 10 - Central GA | 10 - Central GA |
| AR2_0513 | ED149636 | General Research Use | No | Female | White | 67 | 10 - Central GA | 10 - Central GA |
| AR2_0685 | ED149554 | General Research Use | No | Female | White | 68 | 10 - Central GA | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1195 | ED148252 | General Research Use | No | Female | White | 80 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1230 | ED148799 | General Research Use | No | Male | White | 75 | 10 - Central GA | 10 - Central GA |
| AR2_2069 | ED148728 | General Research Use | No | Male | White | 82 | 10 - Central GA | 10 - Central GA |
| AR2_2078 | ED148447 | General Research Use | No | Female | White | 68 | 10 - Central GA | 10 - Central GA |
| AR2_2125 | ED149845 | General Research Use | No | Female | White | 83 | 10 - Central GA | 10 - Central GA |
| AR2_2855 | ED149251 | General Research Use | No | Female | White | 68 | 10 - Central GA | 10 - Central GA |
| AR2_2954 | ED148073 | General Research Use | No | Male | White | 65 | 10 - Central GA | 10 - Central GA |
| AR2_2989 | ED148288 | General Research Use | No | Female | White | 81 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2996 | ED148806 | General Research Use | No | Female | White | 69 | 10 - Central GA | 10 - Central GA |
| AR2_0105 | ED148642 | General Research Use | No | Male | White | 83 | 10 - Central GA | 10 - Central GA |
| AR2_0148 | ED148547 | General Research Use | No | Female | White | 83 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0824 | ED148333 | General Research Use | No | Female | White | 81 | 10 - Central GA | 10 - Central GA |
| AR2_1224 | ED148226 | General Research Use | No | Female | White | 59 | 10 - Central GA | 10 - Central GA |
| AR2_1346 | ED149500 | General Research Use | No | Male | White | 73 | 10 - Central GA | 10 - Central GA |
| AR2_1573 | ED148710 | General Research Use | No | Female | White | 75 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2273 | ED149904 | General Research Use | No | Female | White | 83 | 10 - Central GA | 10 - Central GA |
|
|
|